Greenwich LifeSciences Cash and Cash Equivalents 2011-2026 | GLSI

Annual Cash and Cash Equivalents Greenwich LifeSciences

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.09 M	6.99 M	13.5 M	27.2 M	28.7 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
28.7 M	4.09 M	16.1 M

Quarterly Cash and Cash Equivalents Greenwich LifeSciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.81 M	3.13 M	2.75 M	4.09 M	5.82 M	7.22 M	5.51 M	6.99 M	9.14 M	10.9 M	11.9 M	13.5 M	15.6 M	17.2 M	19.7 M	27.2 M	28.9 M	29.8 M	30.4 M	28.7 M	28.7 M	28.7 M	28.7 M	6.84 K	6.84 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
30.4 M	6.84 K	14.7 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	320 M	$ 22.57	0.04 %	$ 3.74 B	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
Akebia Therapeutics AKBA	185 M	$ 1.41	-1.4 %	$ 363 M	USA
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
BioNTech SE BNTX	7.68 B	$ 91.98	-0.11 %	$ 27.2 B	Germany
Aytu BioScience AYTU	31 M	$ 2.56	-3.76 %	$ 16.1 M	USA
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.85	-1.39 %	$ 9.26 B	Australia
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	170 M	$ 20.87	2.3 %	$ 976 M	USA
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.17	-0.24 %	$ 446 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Arcutis Biotherapeutics ARQT	42.9 M	$ 24.57	-0.16 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
CymaBay Therapeutics CBAY	207 M	-	-	$ 3.45 B	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Cabaletta Bio CABA	83 M	$ 3.17	2.59 %	$ 319 M	USA
Codiak BioSciences CDAK	76.9 M	-	-55.98 %	$ 2.15 M	USA
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
Avid Bioservices CDMO	38.1 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	190 M	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 2.93	-4.87 %	$ 6.38 B	Israel
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Checkpoint Therapeutics CKPT	6.6 M	-	-	$ 169 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Celldex Therapeutics CLDX	28.9 M	$ 33.62	3.73 %	$ 2.23 B	USA
Concert Pharmaceuticals CNCE	142 M	-	-	$ 401 M	USA
Akari Therapeutics, Plc AKTX	2.6 M	$ 3.92	1.03 %	$ 264 B	Britain
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Celsion Corporation CLSN	8.78 M	-	-6.63 %	$ 13.9 M	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA